Increased expression of VCAM-1 and ICAM-1 has been shown in SLE tissues such as the skin [43] and heart [40] and high levels of VCAM-1, associated with enhanced systemic TNF-α activity, was recently demonstrated to characterize SLE patients with manifest cardiovascular disease [47]. Here, ICAM1 is linked to cardiovascular disorder.